Filters
The novel rifabutin-based triple therapy (RHB-105) delivers promising outcomes as first-line empirical treatment for Helicobacter pylori eradication, according to the results of a phase III, double blind trial. This therapy addresses the challenge of rising antibiotic resistance in the current environment.
Men who have sex with men (MSM) who are on pre-exposure prophylaxis (PrEP) for HIV are at risk of hepatitis C virus (HCV) infections, a new study has found.
Frontline health workers caring for patients with the novel coronavirus disease (COVID-19) may benefit from effective interventions derived from previous emerging virus outbreaks, which can be employed to help mitigate psychological distress, suggest the results of a rapid review and meta-analysis.
A trial vaccine for the prevention of COVID-19 is underway with the first US participants being dosed in the Phase 1/2 clinical trial. Known as the BNT162 vaccine programme, the trials are a collaboration between Pfizer Inc. and BioNTech SE, and is part of a global development programme with Germany and the US taking the lead in having the first cohorts to be vaccinated. Germany started the study 1 week earlier.
Singapore’s Ministry of Health (MOH) has confirmed 876 new cases of COVID-19 infection on May 10. Two casualties have been recorded on May 6, bringing the total COVID-19 deaths in the city-state to 20. Older age seems a common factor among them.
After months of work disruption, profound worrying, social distancing, and isolation, SARS-CoV-2* still rages on, unyielding to human interventions.
Use of the interleukin(IL)-1 inhibitor anakinra led to clinical improvements in patients with coronavirus disease (COVID)-19, acute respiratory distress syndrome (ARDS), and systemic inflammation who are under noninvasive ventilation outside the intensive care unit (ICU), an Italian retrospective study has shown.
Majority of patients with confirmed SARS-CoV-2 infections appear to be capable of mounting an immunoglobulin (Ig) G immune response to the disease, according to a new pre-print.
A number of patients with coronavirus disease 2019 (COVID-19) present with diarrhoea, and this group may suffer discomfort longer and show persistent positive SARS-CoV-2 in stool specimens as compared with patients who do not have the symptom, as shown in a study.
The incidence of thromboembolic events in patients with the novel coronavirus disease (COVID-19) is surprisingly high, which suggests a significant role of COVID-19–induced coagulopathy, according to the results of a prospective cohort study in Germany.
